HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Support the early adoption of priority formulations and diagnostics and take steps to facilitate their wider roll-out, including by developing introductory guidance, materials, and other tools for health facilities.
Implementing Partners, and Faith-Based Organizations
Sub-Actions & Milestones
Develop and distribute introductory guidance, materials, and other tools for RAL in 2018
-
PEPFAR is working with Merck and other partners on a plan for assisted introduction of RAL granules for newborns. The plan is to start with introduction in one country and, in the context of that introduction, develop educational and training materials that will be used for supporting implementation of RAL granule use for newborn in other countries where birth testing is being implemented.
-
Take steps to facilitate their wider roll-out, including by developing introductory guidance, materials, and other tools for health facilities.
Implementing Partners and FBO's
EGPAF and CHAI are beginning preparations for introduction of DTG and RAL (EGPAF), including production of a DTG introduction toolkit. DNDi is working with in-country partners on expand uptake of LPV/r solid formulations for the roll-out of introductory materials
-
Develop and distribute introductory guidance, materials, and other tools for DTG in 2018
-
-
Milestone ongoing
Develop and distribute introductory guidance, materials, and other tools for 4-in-1 granules in 2018
-
-
-
Support the early adoption of priority formulations and diagnostics
Implementing Partners and FBO's
GAP-f partners have been discussing with ViiV and regulatory authorities to determine the best regulatory pathways for pediatric DTG (10 mg scored and 50 mg scored tablets) and ways to accelerate registration and introduction of DTG and RAL at country level.
-
Work with ViiV on registration of DTG for children
CHAI
In November, CHAI issued in collaboration with ViiV an RFP for development of generic pediatric formulations of DTG, with the announcement of manufacturers selected expected in February.
-
-
-
-
-
Updates
Notes
Responsible